New study highlights importance of heart disease treatments targeting both cholesterol and inflammation
29 July 2026
Study identifies 12 proteins that could lead to new heart disease treatments targeting both cholesterol and inflammation.
Tommy’s National Centre for Miscarriage Research celebrates ten years of progress
28 July 2026
Tommy's National Centre for Miscarriage Research marks ten years of pioneering research, with the Nuffield Department of Women's & Reproductive Health now leading the next phase of its work to improve miscarriage care and prevention.
Trial exploring effects of drug on liver in psoriasis patients recruits first UK patient
28 July 2026
The first patient in the UK has been recruited to a clinical trial investigating how a new drug affects liver inflammation and scarring in people with psoriatic disease using a new non-invasive MRI scanning technique.
First volunteer vaccinated in the world's first Bundibugyo ebolavirus vaccine trial
24 July 2026
The University of Oxford’s Oxford Vaccine Group has today successfully vaccinated the first volunteer in the world’s first clinical trial of a vaccine designed to protect against Bundibugyo ebolavirus (BDBV).
MORU’s contribution to ASEAN health highlighted during The Princess Royal’s Thailand visit
22 July 2026
The visit highlighted MORU’s longstanding contribution to health across Thailand and the wider ASEAN region, and the value of collaboration between Mahidol University and Oxford's Nuffield Department of Medicine.
Global study finds many countries are overusing powerful antibiotics while millions lack access to the medicines they need
22 July 2026
Countries around the world are prescribing too many broad-spectrum antibiotics while millions of people still cannot access the medicines they need to treat serious infections, according to a new study led by researchers from City St George's, University of London and the University of Oxford's Nuffield Department of Primary Care Health Sciences.
Blood pressure-lowering benefits emerge early and do not build up over time
21 July 2026
An analysis of data from more than 358,000 participants has found that the cardiovascular benefits of blood pressure-lowering treatment are established within months of starting therapy and do not progressively increase with longer treatment.
A third of adolescents have seen self-harm content online, despite most not looking for it – new Oxford study
21 July 2026
One in three young people have seen self-harm content online in the course of the previous month, despite the majority not actively seeking it out, according to a major new study from the University of Oxford.
Can children shape their parents’ lives? Study suggests family influence flows both ways
21 July 2026
Children’s characteristics may influence family dynamics over time, challenging the traditional view that influence flows primarily from parents to children, according to a new study.
Oxford-led newborn screening pilot expanded to include all babies in England
20 July 2026
Every newborn baby in England will be screened for spinal muscular atrophy (SMA), following the expansion of a pioneering University of Oxford-led pilot that introduced the country’s first routine test for the condition.
Salsa classes shown to reduce depressive symptoms in young adults
15 July 2026
A new trial led by the University of Oxford suggests it may offer a promising, accessible addition to youth wellbeing support.
Infections linked to higher risk of brain and mental health conditions for up to two years
15 July 2026
A large study of more than 1 million matched patient pairs has found that serious infections across the body are followed by increased risks of psychiatric and neurological diagnoses, especially in adults.
Study shows AI can be safely deployed in NHS prostate cancer diagnosis
15 July 2026
Findings from the landmark Articulate Pro study have now been published, marking a major milestone for the use of artificial intelligence (AI) in NHS histopathology laboratories and demonstrating its potential to improve and standardise prostate cancer diagnosis.
World’s first Phase I Bundibugyo ebolavirus vaccine trial launched by Oxford Vaccine Group
13 July 2026
The University of Oxford’s Oxford Vaccine Group has launched the world’s first Phase I clinical trial, BD-Ebov, of a vaccine against Bundibugyo ebolavirus (BDBV), in response to the ongoing outbreak in the Democratic Republic of the Congo and neighbouring Uganda.
Smoking deaths responsible for stalled gains in life expectancy in the USA
10 July 2026
An analysis of nearly three decades of mortality data in the United States of America (USA) published in Nature Health has found that cigarette smoking accounted for nearly two-thirds of excess deaths among White Americans with lower levels of education.
Researchers use OpenSAFELY to deliver first-ever large-scale analysis of Pharmacy First consultations in GP clinical systems
10 July 2026
Conducting the first-ever, large-scale analysis of Pharmacy First consultations in GP records, researchers at the Bennett Institute for Applied Data Science, London School of Hygiene and Tropical Medicine, University of Nottingham, University of Manchester, and UKHSA used OpenSAFELY to analyse the programme’s service uptake, data quality, and integration into primary care systems.
World-first perfused pancreas transplant marks major Oxford study milestone
9 July 2026
A clinical study at the University of Oxford has recruited its first participant, marking the world’s first successful transplantation of a perfused human pancreas and a major advance in efforts to improve organ preservation for transplantation.
Professor Adrian Hill wins European Inventor Award 2026 for highly effective malaria vaccine
7 July 2026
The European Patent Office (EPO) has awarded Professor Sir Adrian Hill the European Inventor Award 2026 in the Research category for developing the R21/Matrix-M malaria vaccine.
The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences team wins Award for Excellence for transforming ulcerative colitis care
6 July 2026
The Sagittarius Team, a pioneering partnership between the University of Oxford and Oxford University Hospitals (OUH) has been recognised with the OUH Award for Excellence 2026 for transforming care for people experiencing a relapse of ulcerative colitis while advancing translational research.
Professor Kokila Lakhoo awarded the Denis Browne Gold Medal for lifetime contributions to paediatric surgery
2 July 2026
Professor Kokila Lakhoo, Professor of Paediatric Surgery in the Nuffield Department of Surgical Sciences (NDS), University of Oxford, has been awarded the Denis Browne Gold Medal, the highest honour bestowed by the British Association of Paediatric Surgeons (BAPS). The award recognises outstanding lifetime contributions to paediatric surgery worldwide and is presented annually at the Association's Annual Congress.